Galera Therapeutics Inc. (GRTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Galera Therapeutics Inc.

OTC: GRTX · Real-Time Price · USD
0.03
0.00 (9.09%)
At close: Apr 04, 2025, 2:24 PM

Galera Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
8.46M 10.75M 13.47M 18.26M 24.38M 24.3M 25.69M 4.27M 12.73M 17.38M 19.64M 19.86M 17.63M 38.47M 13.69M
Short-Term Investments
n/a n/a n/a n/a 3.98M 14.45M 22.06M 27.33M 30.04M 34.63M 41.3M 51.36M 71.07M 28.06M 43.83M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 51.36M n/a n/a n/a
Other Long-Term Assets
2K 90K 90K 90K 1.95M 1.64M 1.91M 1.88M 2.09M 2.1M 1.95M 1.96M 1.63M 1.8M 1.48M
Receivables
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 37.5M n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
444K 678K 1.72M 3.37M 2.88M 3.25M 6.49M 6.94M 2.15M 3.18M 4.33M 6.17M 3.98M n/a 6.72M
Total Current Assets
8.9M 11.96M 15.19M 21.63M 31.25M 42M 54.24M 38.53M 44.92M 55.19M 65.28M 77.39M 92.69M 108.86M 64.24M
Property-Plant & Equipment
n/a 1.19M 1.24M 1.28M 1.45M 1.5M 418K 481K 570K 654K 738K 823K 1.31M 1.47M 1.63M
Goodwill & Intangibles
n/a 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M 3.14M
Total Long-Term Assets
2K 4.42M 4.46M 4.51M 6.53M 6.27M 5.47M 5.5M 5.8M 5.89M 5.82M 5.92M 6.08M 6.41M 6.25M
Total Assets
8.9M 16.38M 19.65M 26.14M 37.78M 48.28M 59.71M 44.04M 50.71M 61.08M 71.1M 83.31M 98.77M 115.27M 70.49M
Account Payables
296K 812K 1.05M 1.38M 3.71M 5.52M 5.94M 3.58M 3.59M 3.59M 4.13M 5.04M 7.18M 8.27M 9.22M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a 133K n/a 128K n/a 44K 109K 172K 234K 258K 271K 284K 296K
Other Current Liabilities
618K 825K 45K -12K 1.26M 1.66M 818K 2.61M 2.01M 1.33M 711K 1.78M 1.71M 1.02M 535K
Total Current Liabilities
914K 2.13M 2.01M 4.96M 12.63M 13.62M 13.27M 13.38M 11.63M 10.99M 10.93M 12.94M 15.72M 16.84M 15.86M
Long-Term Debt
n/a n/a 151.05M n/a n/a n/a n/a 139.63M n/a n/a n/a n/a 110K 172K 235K
Other Long-Term Liabilities
151.05M 151.05M n/a 151.05M 150.34M 148.26M 144.06M n/a 136.31M 133.06M 130.37M 128.06M 125.72M 123.33M 64.46M
Total Long-Term Liabilities
151.05M 152.29M 152.33M 152.37M 151.7M 149.65M 144.06M 139.84M 136.58M 133.34M 130.64M 128.38M 126.21M 123.94M 65.2M
Total Liabilities
151.96M 154.41M 154.34M 157.33M 164.33M 163.28M 157.33M 153.22M 148.22M 144.32M 141.57M 141.31M 141.93M 140.79M 81.06M
Total Debt
n/a 1.19M 152.26M 152.3M 1.29M 1.32M n/a 44K 109K 172K 234K 302K 381K 456K 531K
Common Stock
54K 54K 54K 54K 54K 44K 43K 28K 27K 27K 27K 26K 26K 26K 25K
Retained Earnings
-451.43M -445.85M -441.79M -437.41M -431.82M -416.75M -396.03M -378.32M -362.14M -346.1M -331.55M -316.1M -299.3M -276.67M -254.28M
Comprehensive Income
n/a n/a n/a 0.00 0.00 5K 16K -22K -93K -110K -61K -14K -2K 3K 10K
Shareholders Equity
-143.06M -138.03M -134.69M -131.19M -126.55M -115M -97.61M -109.18M -97.5M -83.25M -70.47M -58M -43.17M -25.52M -10.57M
Total Investments
n/a n/a n/a n/a 3.98M 14.45M 22.06M 27.33M 30.04M 34.63M 41.3M 51.36M 71.07M 28.06M 43.83M